Profile | GDS5420 / 214605_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 492.41 | 67 |
GSM1296119 | B_lesional_pre-dose | 1000.4 | 79 |
GSM1296076 | C_lesional_pre-dose | 1304.71 | 83 |
GSM1296092 | D_lesional_pre-dose | 756.8 | 75 |
GSM1296103 | E_lesional_pre-dose | 313.36 | 60 |
GSM1296078 | F_lesional_pre-dose | 1194.3 | 81 |
GSM1296107 | G_lesional_pre-dose | 1132.14 | 81 |
GSM1296109 | H_lesional_pre-dose | 696.31 | 73 |
GSM1296080 | I_lesional_pre-dose | 453.35 | 66 |
GSM1296090 | J_lesional_pre-dose | 592.97 | 71 |
GSM1296074 | K_lesional_pre-dose | 1059.06 | 80 |
GSM1296111 | L_lesional_pre-dose | 1401.66 | 85 |
GSM1296099 | M_lesional_pre-dose | 602.99 | 70 |
GSM1296086 | O_lesional_pre-dose | 613.07 | 71 |
GSM1296117 | P_lesional_pre-dose | 1344.15 | 84 |
GSM1296113 | Q_lesional_pre-dose | 990.67 | 79 |
GSM1296096 | R_lesional_pre-dose | 585 | 70 |
GSM1296105 | S_lesional_pre-dose | 460.21 | 66 |
GSM1296098 | T_lesional_pre-dose | 516.96 | 68 |
GSM1296101 | U_lesional_pre-dose | 477.33 | 66 |
GSM1296121 | V_lesional_pre-dose | 713.76 | 74 |
GSM1296088 | W_lesional_pre-dose | 414.55 | 65 |
GSM1296082 | X_lesional_pre-dose | 827.31 | 76 |
GSM1296115 | Y_lesional_pre-dose | 1080.77 | 80 |
GSM1296084 | Z_lesional_pre-dose | 462.14 | 66 |
GSM1296072 | B_lesional_day8 | 811.14 | 76 |
GSM1296069 | L_lesional_day8 | 1160.5 | 82 |
GSM1296071 | P_lesional_day8 | 621.16 | 71 |
GSM1296070 | Y_lesional_day8 | 1144.21 | 82 |
GSM1296073 | V_lesional_day8 | 943.53 | 78 |
GSM1296034 | A_lesional_day15 | 405.34 | 63 |
GSM1296041 | G_lesional_day15 | 1448.39 | 85 |
GSM1296035 | R_lesional_day15 | 685.26 | 73 |
GSM1296038 | U_lesional_day15 | 722.63 | 74 |
GSM1296047 | B_lesional_day15 | 531.96 | 69 |
GSM1296039 | E_lesional_day15 | 845.59 | 77 |
GSM1296042 | H_lesional_day15 | 1206.5 | 82 |
GSM1296043 | L_lesional_day15 | 1127.43 | 81 |
GSM1296037 | M_lesional_day15 | 281.06 | 57 |
GSM1296046 | P_lesional_day15 | 495.82 | 67 |
GSM1296044 | Q_lesional_day15 | 568.88 | 69 |
GSM1296045 | Y_lesional_day15 | 1096.53 | 81 |
GSM1296025 | C_lesional_day15 | 350.47 | 62 |
GSM1296033 | D_lesional_day15 | 538.42 | 69 |
GSM1296027 | I_lesional_day15 | 378.63 | 64 |
GSM1296032 | J_lesional_day15 | 278.92 | 57 |
GSM1296024 | K_lesional_day15 | 347.29 | 62 |
GSM1296031 | W_lesional_day15 | 280.98 | 57 |
GSM1296028 | X_lesional_day15 | 321.54 | 60 |
GSM1296029 | Z_lesional_day15 | 271.33 | 57 |
GSM1296026 | F_lesional_day15 | 981.06 | 79 |
GSM1296030 | O_lesional_day15 | 355.23 | 63 |
GSM1296040 | S_lesional_day15 | 357.91 | 62 |
GSM1296036 | T_lesional_day15 | 352.2 | 61 |
GSM1296048 | V_lesional_day15 | 829.07 | 76 |
GSM1296059 | A_lesional_day43 | 349.32 | 62 |
GSM1296066 | G_lesional_day43 | 1133.69 | 81 |
GSM1296060 | R_lesional_day43 | 658.46 | 72 |
GSM1296063 | U_lesional_day43 | 783.07 | 75 |
GSM1296064 | E_lesional_day43 | 662.6 | 73 |
GSM1296067 | H_lesional_day43 | 455.59 | 65 |
GSM1296062 | M_lesional_day43 | 326.16 | 60 |
GSM1296068 | Q_lesional_day43 | 473.09 | 66 |
GSM1296050 | C_lesional_day43 | 435.3 | 66 |
GSM1296057 | D_lesional_day43 | 435.09 | 65 |
GSM1296052 | I_lesional_day43 | 325.34 | 61 |
GSM1296054 | J_lesional_day43 | 287.06 | 58 |
GSM1296049 | K_lesional_day43 | 456.24 | 66 |
GSM1296055 | W_lesional_day43 | 449.79 | 66 |
GSM1296053 | X_lesional_day43 | 309.19 | 59 |
GSM1296058 | Z_lesional_day43 | 378.04 | 63 |
GSM1296051 | F_lesional_day43 | 741.02 | 74 |
GSM1296056 | O_lesional_day43 | 556 | 70 |
GSM1296065 | S_lesional_day43 | 710.79 | 73 |
GSM1296061 | T_lesional_day43 | 464.28 | 66 |
GSM1296095 | A_non-lesional_pre-dose | 666.3 | 73 |
GSM1296120 | B_non-lesional_pre-dose | 542.33 | 69 |
GSM1296077 | C_non-lesional_pre-dose | 431.46 | 65 |
GSM1296093 | D_non-lesional_pre-dose | 306.46 | 59 |
GSM1296104 | E_non-lesional_pre-dose | 283.79 | 58 |
GSM1296079 | F_non-lesional_pre-dose | 431.77 | 66 |
GSM1296108 | G_non-lesional_pre-dose | 483.92 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 476.99 | 66 |
GSM1296081 | I_non-lesional_pre-dose | 353.68 | 62 |
GSM1296091 | J_non-lesional_pre-dose | 344.74 | 62 |
GSM1296075 | K_non-lesional_pre-dose | 482.82 | 68 |
GSM1296112 | L_non-lesional_pre-dose | 618.29 | 71 |
GSM1296100 | M_non-lesional_pre-dose | 326.43 | 60 |
GSM1296087 | O_non-lesional_pre-dose | 334.63 | 62 |
GSM1296118 | P_non-lesional_pre-dose | 384.47 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 606.91 | 71 |
GSM1296097 | R_non-lesional_pre-dose | 492.41 | 68 |
GSM1296106 | S_non-lesional_pre-dose | 466.29 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 310.23 | 58 |
GSM1296122 | V_non-lesional_pre-dose | 313.73 | 59 |
GSM1296089 | W_non-lesional_pre-dose | 302.31 | 58 |
GSM1296083 | X_non-lesional_pre-dose | 343.7 | 61 |
GSM1296116 | Y_non-lesional_pre-dose | 749.5 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 321.7 | 60 |